SMAC-30: The Thirty-Marker Conversation With Your Blood
- Maria Sazhina
- Jul 19
- 4 min read
Long before a symptom announces itself, your blood has usually already said something. The SMAC-30 panel is how we learn to listen.
There is a particular kind of quiet that settles over a consultation room when someone realises, mid-sentence, that they have been "fine" for years without ever actually checking. Not unwell — just unmeasured. The blood pressure cuff, perhaps, at a pharmacy once. A general checkup with a handful of numbers scrawled on a printout. But nothing that asked the deeper question: what is actually happening, cell by cell, inside a body that still feels, on the surface, entirely capable?
This is the gap the SMAC-30 exists to close.
The name has old roots. SMAC stands for Sequential Multiple Analysis — Computer, a term first coined decades ago when automated laboratory analyzers made it possible, for the first time, to run dozens of blood chemistries from a single draw instead of ordering each test by hand. What began as a twelve- or twenty-marker screen has, in the decades since, been refined and extended — and at EuroMed, the SMAC-30 is our own broadened version of that idea: thirty biochemical markers drawn from a single sample, read together rather than in isolation.
That distinction — together, rather than in isolation — is the entire philosophy of preventive medicine in one phrase. A single elevated liver enzyme means very little on its own; it could be a heavy training week, a late night, a glass of wine the evening before. But that same enzyme read alongside kidney markers, lipid trends, glucose regulation, and mineral balance starts to tell a story with actual narrative weight. Patterns emerge that no single test could reveal.
WHAT THIRTY MARKERS ACTUALLY COVER
Rather than a list of thirty individual line items — most of which mean little without clinical context — it is more useful to think of the SMAC-30 as six conversations happening at once, each with a different organ system:
Metabolic status. Glucose — the single most-watched number in preventive medicine, and often the first place a shifting metabolism shows itself, years before any diagnosis would.
Kidney function. Urea, blood urea nitrogen (BUN), creatinine, uric acid, and the BUN/creatinine ratio describe how efficiently the kidneys are clearing waste from circulation — often the earliest measurable signal of strain, well before any change in how a person feels day to day.
Lipid metabolism. Total cholesterol, HDL, LDL, VLDL, triglycerides, and the atherogenic index — the long-range weather forecast for cardiovascular health, and one of the few panels where intervention today measurably changes risk a decade from now.
Liver function. AST (SGOT), ALT (SGPT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), lactate dehydrogenase (LDH), and total, direct, and indirect bilirubin — a fuller picture of how the liver is processing everything from medication to metabolic load, and how efficiently it is doing so under the pressures of modern life: travel, alcohol, medication, stress.
Protein status. Total protein, albumin, globulin, and the A/G ratio — markers of nutritional status, immune function, and how well the body is synthesising the proteins it depends on.
Electrolyte and mineral balance. Sodium, potassium, chloride, calcium, phosphorus, and iron — the quiet infrastructure behind nerve signalling, muscle function, hydration status, bone metabolism, and oxygen transport.
None of these six categories is new information to medicine. What is different is the discipline of reading all thirty markers as one panel, at one moment, for one person — and returning to that same panel at intervals, so the story being told is not a single frame but a trend line.
WHY A SINGLE DRAW, READ TOGETHER, CHANGES THE CONVERSATION
Most people who come through EuroMed's doors are not in crisis. They are, by every conventional measure, well. That is precisely the population for whom a panel like the SMAC-30 does its most valuable work — not diagnosing disease, but surfacing the small deviations that precede it. A slightly rising creatinine year over year. A lipid ratio drifting the wrong direction despite a stable weight. A fasting glucose that is still "normal" but has quietly climbed three years running.
Caught here, these are not diagnoses. They are invitations — to adjust, to investigate further, to return in six months rather than wait for the version of this story that arrives as an emergency.
This is the quiet argument at the centre of preventive medicine: that the most important moment in a patient's care is very often the one where nothing appears to be wrong yet. The SMAC-30 is one of the instruments that lets us stand in that moment with useful information, rather than in the dark.
"A single number rarely tells the truth. Thirty of them, read together, usually do."
Every longevity conversation eventually returns to the same unglamorous truth: the body has been giving us data all along. The SMAC-30 does not promise certainty, and it is not a verdict. It is a single, comprehensive draw of blood, read as a whole — one more way of paying attention before attention is the only option left.
The SMAC-30 panel is available as part of every EuroMed baseline assessment. Ask your physician how it fits into your preventive programme.
Comments